| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.6 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.6 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.014 | 0.6 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.6 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.6 |